The Federal Minister for Health, the Hon Greg Hunt MP announced more than $38 million funding for the MRFF Rare Cancers, Rare Diseases and Unmet Need Clinical Trials program, which focuses on clinical trials that address areas of health burden and unmet need including brain cancer.
The University of Sydney was successful in securing more than $7 million for five research projects which will enhance clinical trial activity, and treatments and cures for Australians with rare cancers and diseases.
“This funding will allow our health and medical researchers to undertake important clinical trials, which could help increase survival rates of those with rare cancers and diseases. These include trials for children with chronic kidney disease, a rare and devastating disease for children, and people with the rapidly fatal motor neuron disorder, amyotrophic lateral sclerosis (ALS),” said Deputy Vice-Chancellor (Research) Professor Duncan Ivison.
Grants awarded through the competitive MRFF program include:
This is the third round of grants announced the under Rare Cancers, Rare Diseases and Unmet Need Clinical Trials program taking the total funding announced under this program to $75 million.